Company: CI
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001739940-25-000021
Chunk: 244

Company: Cigna Group
Filing Date: 2025-05-02
Form: 10-Q
Item: Part II, Item 12
Chunk 244
---
 impaired and recorded a $1.8 billion loss in Net investment losses in the Company's Consolidated Statements of Income. Observable price changes for equity securities with no readily determinable fair value were not material for the three months ended March 31, 2025 and March 31, 2024.

22

C.Fair Value Disclosures for Financial Instruments Not Carried at Fair Value

The following table includes the Company's financial instruments not recorded at fair value but for which fair value disclosure is required. In addition to universal life products and finance leases, financial instruments that are carried in the Company's Consolidated Balance Sheets at amounts that approximate fair value are excluded from the following table.Classification in Fair Value HierarchyMarch 31, 2025December 31, 2024(In millions)Fair ValueCarrying ValueFair ValueCarrying ValueCommercial mortgage loansLevel 3$1,228 $1,294 $1,256 $1,351 Long-term debt, including current maturities, excluding finance leasesLevel 2$28,149 $30,371 $28,392 $31,008